Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial
NCT ID: NCT04427930
Last Updated: 2023-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE3
129 participants
INTERVENTIONAL
2020-04-13
2027-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Follow-up Study for Participants Jointstem Clinical Trial
NCT03509025
A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis
NCT03990805
Clinical Trial to Evaluate Efficacy and Safety of JOINTSTEM in Patients With Degenerative Arthritis
NCT02658344
Follow-up Study for Participants of Jointstem Investigator Initiated Trial by Arthroscopy
NCT04825730
Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy After JOINTSTEM Administration
NCT04821102
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
JOINTSTEM
Long Term Follow-up after Jointstem Transplantation
JOINTSTEM
Autologous Adipose Tissue derived MSCs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
JOINTSTEM
Autologous Adipose Tissue derived MSCs
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participates who signed informed consent document of this study
Exclusion Criteria
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
R-Bio
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
KANGIL KIM
Role: PRINCIPAL_INVESTIGATOR
KyungHee University Gangdong Hospital
WOOSUK LEE
Role: PRINCIPAL_INVESTIGATOR
Gangnam Severance Hospital
KICHEOR BAE
Role: PRINCIPAL_INVESTIGATOR
Keimyung University Dongsan Medical Center
YONG IN
Role: PRINCIPAL_INVESTIGATOR
The Catholic University of Korea
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Keimyung University Dongsan Medical Center
Daegu, , South Korea
KyungHee University Gangdong Hospital
Seoul, , South Korea
Gangnam Severance Hospital
Seoul, , South Korea
The Catholic University of Korea, Seoul ST. Mary's Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BSR-CTph3-JS1_FU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.